MedPath

Add-on study of new biomarkers in Type 2 Diabetes Mellitus

Conditions
Type 2 Diabetes Mellitus, wash-out and restart of metformin, explorative biomarkers of inflammation
Registration Number
NL-OMON20896
Lead Sponsor
no sponsor
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Diabetes Mellitus type 2 patients eligible to start wash-out as per criteria in new compound studies

Exclusion Criteria

N/A

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath